Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyherbal capsule in chronic Hepatitis B
NCT02899130Unknown
- Sponsor
- Composite Interceptive Med-Science Laboratories
- Start
- Oct 2016
- Primary completion
- Jun 2018
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of phyllanthus niruri extract, boerhavia diffusa and picrorhiza kurroa in Chronic Hepatitis B (CHB) (2 arms), sponsored by Composite Interceptive Med-Science Laboratories. Primary endpoint: Change in mean Hepatitis B Virus (HBV) DNA at 12 months. Status: unknown.
02
Drugs
phyllanthus niruri extractboerhavia diffusapicrorhiza kurroa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02899130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02899130.